Ambikanandan, M., & Lalan, M. S.
(2009). Role of natural polysaccharides in treatment and control of diabetes. Chemistry
and medicinal value, 347-373.
Barros, L., Cruz, T., Baptista, P.,
Estevinho, L. M., & Ferreira, I. C. (2008). Wild and commercial mushrooms
as source of nutrients and nutraceuticals. Food and Chemical Toxicology,
46(8), 2742-2747.
Boruta, T. (2018). Uncovering the
repertoire of fungal secondary metabolites: From Fleming's laboratory to the
International Space Station. Bioengineered, 9(1), 12-16.
CFR Ferreira, I., A Vaz, J.,
Vasconcelos, M. H., & Martins, A. (2010). Compounds from wild mushrooms
with antitumor potential. Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 10(5),
424-436.
De Silva, D. D., Rapior, S., Hyde, K.
D., & Bahkali, A. H. (2012). Medicinal mushrooms in prevention and control
of diabetes mellitus. Fungal Diversity, 56, 1-29.
Deveci, E., Çayan, F., Tel-Çayan, G.,
& Duru, M. E. (2021). Inhibitory activities of medicinal mushrooms on
α-amylase and α-glucosidase-enzymes related to type 2 diabetes. South
African Journal of Botany, 137, 19-23.
Dias, D. A., Urban, S., & Roessner,
U. (2012). A historical overview of natural products in drug discovery. Metabolites,
2(2), 303-336.
Evans, W. C. (2009). Trease and
Evans' pharmacognosy. Elsevier Health Sciences.
Ha, J. W., Kim, J., Kim, H., Jang, W.,
& Kim, K. H. (2020). Mushrooms: An important source of natural bioactive
compounds. Natural Product Sciences, 26(2), 118-131.
Jeong, Y. T., Yang, B. K., Jeong, S.
C., Kim, S. M., & Song, C. H. (2008). Ganoderma applanatum: a promising
mushroom for antitumor and immunomodulating activity. Phytotherapy Research:
An International Journal Devoted to Pharmacological and Toxicological
Evaluation of Natural Product Derivatives, 22(5), 614-619.
Joseph, B. S., Kumbhare, P. H., &
Kale, M. C. (2013). Preliminary phytochemical screening of selected Medicinal
Plants. Int. Res. J. of Science & Engineering, 1(2), 55-62.
Keller, N. P., Turner, G., &
Bennett, J. W. (2005). Fungal secondary metabolism—from biochemistry to
genomics. Nature Reviews Microbiology, 3(12), 937-947.
Kumar, K., Mehra, R., Guiné, R. P.,
Lima, M. J., Kumar, N., Kaushik, R. & Kumar, H. (2021). Edible Mushrooms: A
comprehensive review on bioactive compounds with health benefits and processing
aspects. Foods, 10(12), 2996.
Lindequist, U., Niedermeyer, T. H.,
& Jülich, W. D. (2005). The pharmacological potential of mushrooms. Evidence-based
complementary and alternative medicine, 2(3), 285-299.
Lo, H. C., & Wasser, S. P. (2011).
Medicinal mushrooms for glycemic control in diabetes mellitus: history, current
status, future perspectives, and unsolved problems. International journal of
medicinal mushrooms, 13(5).
Muszyńska, B., Sułkowska-Ziaja, K.,
& Ekiert, H. (2013). Phenolic acids in selected edible basidiomycota
species: Armillaria mellea, Boletus badius, Boletus edulis, Cantharellus
cibarius, Lactarius deliciosus and Pleurotus ostreatus. Acta Scientiarum
Polonorum. Hortorum Cultus, 12(4).
Nowak, R., Olech, M., & Nowacka, N.
(2014). Plant polyphenols as chemopreventive agents. Polyphenols in human
health and disease, 1289-1307.
Öztürk, M., Tel-Çayan, G., Muhammad,
A., Terzioğlu, P., & Duru, M. E. (2015). Mushrooms: a source of exciting
bioactive compounds. Studies in natural products chemistry, 45,
363-456.
Papoutsis, K., Zhang, J., Bowyer, M.
C., Brunton, N., Gibney, E. R., & Lyng, J. (2021). Fruit, vegetables, and
mushrooms for the preparation of extracts with α-amylase and α-glucosidase
inhibition properties: A review. Food Chemistry, 338, 128119.
Qiang, X., YongLie, C., & QianBing,
W. (2009). Health benefit application of functional oligosaccharides. Carbohydrate
polymers, 77(3), 435-441.
Sato, M., Tai, T., Nunoura, Y., Yajima,
Y., Kawashima, S., & Tanaka, K. (2002). Dehydrotrametenolic acid induces
preadipocyte differentiation and sensitizes animal models of
noninsulin-dependent diabetes mellitus to insulin. Biological and
Pharmaceutical Bulletin, 25(1), 81-86.
Sheel, R., Nisha, K., & Kumar, J.
(2014). Preliminary phytochemical screening of methanolic extract of
Clerodendron infortunatum. IOSR Journal of Applied Chemistry, 7(1),
10-13.
Stojkovic, D., Smiljkovic, M., Ciric,
A., Glamoclija, J., Van Griensven, L., Ferreira, I. C., & Sokovic, M.
(2019). An insight into antidiabetic properties of six medicinal and edible
mushrooms: Inhibition of α-amylase and α-glucosidase linked to type-2 diabetes.
South African Journal of Botany, 120, 100-103.
Suman, K. R., Venkateshwar, C., Samuel,
G., & Gangadhar, R. S. (2013). Phytochemical Screening of some compounds
from plant leaf extracts of Holoptelea integrifolia (Planch.) and Celestrus
emarginata (Grah.) used by Gondu tribes at Adilabad District, Andhrapradesh,
India. Int. J. Eng. Sci. Inv, 2(8), 65-70.
Tiwari, P., Kumar, B., Kaur, M., Kaur,
G., & Kaur, H. (2011). Phytochemical screening and extraction: a review. Internationale
pharmaceutica sciencia, 1(1), 98-106.
Verma, S., Valvi, V., & Shukla, K.
K. (2022). Screening Some Extracellular Enzymes of Wild Mushrooms from Pt.
Ravishankar Shukla University Campus. Journal of Ravishankar University, 35(1),
42–52.
Xiao, C., Wu, Q., Tan, J., Cai, W.,
Yang, X. B., & Zhang, J. M. (2011). Inhibitory effects on α-glucosidase and
hypoglycemic effects of the crude polysaccharides isolated from 11 edible
fungi. J Med Plants Res, 5(32), 6963-6967.